Skip to main content

Find Clinical Trials

Home
Conditions
Neuroendocrine Tumors

Clinical trial condition

Neuroendocrine Tumors

Explore clinical trials studying Neuroendocrine Tumors. Study availability and eligibility vary by location and protocol.

2,768 public trials 494 recruiting studies

Refine in advanced search Browse all conditions

Neuroendocrine Tumors trial results

Not Yet Recruiting

Neoadjuvant SHR-1701 Plus Famitinib With Response-guided Adjuvant Therapy in Resectable Mucosal Melanoma

NCT07517653

Conditions: Melanoma, Neoplasms, Neoplasms by Histologic Type, +9 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

Prospective Cohort Study of Pheochromocytoma/Paraganglioma

NCT07516275

Conditions: Hemodynamic Instability, Intraoperative Complications, Neoplasms, +9 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

PROSECCO: A Phase 2, Single Arm, Neoadjuvant Study Evaluating Combination Cemiplimab, Fianlimab, And Ipilimumab In Patients With Surgically Resectable Melanoma

NCT07511036

Conditions: Melanoma, Neoplasms, Neoplasms by Histologic Type, +9 more
Locations: M.D. Anderson Cancer Center Houston, Texas, United States

View Trial Details

Not Yet Recruiting

Pharmacokinetics, Safety, and Immunogenicity Comparison of Bmab1700 and Opdivo® as Adjuvant Monotherapy in Participants With Melanoma

NCT07476326

Conditions: Diabetes Mellitus, Insulin-Dependent, 12, Melanoma, Neoplasms, +10 more
Locations: High Technology Hospital Medcenter Batumi, Georgia

JSC Vian Kutaisi, Georgia

Institute of Clinical Oncology - Lubliana Street Tbilisi, Georgia

Israel-Georgian Medical Research Clinic Helsicore Tbilisi, Georgia

View all 26 locations

View Trial Details

Not Yet Recruiting

Neoadjuvant Pucotenlimab Combined With Lenvatinib and Temozolomide in Resectable Stage IIB/III Acral Melanoma

NCT07501104

Conditions: Melanoma, Melanoma (Skin Cancer), Neoplasms, +10 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

Screening for Brain Metastases

NCT07492121

Conditions: Breast Cancer Metastatic, Lung Cancer Stage IV, Lung Diseases, +17 more
Locations: University Hospital Zurich Zurich, Canton of Zurich, Switzerland

View Trial Details

Not Yet Recruiting

Phase 2b of RAPA-201 Cell Therapy in Post-PD-(L)-1 Melanoma

NCT06708455

Conditions: Malignant Melanoma, Malignant Melanoma Stage IIIc, Malignant Melanoma Stage IV, +13 more
Locations: Hackensack University Medical Center Hackensack, New Jersey, United States

View Trial Details

Not Yet Recruiting

A Randomized, Double-Blind, Pharmacokinetic Similarity Study to Compare AVT32-DRL_PB With Keytruda® in Participants With Fully Resected Melanoma

NCT07475572

Conditions: Melanoma, Neoplasms, Neoplasms by Histologic Type, +9 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

A Study To Assess the Safety, and Tolerability of Nivolumab + Relatlimab Fixed-Dose Combination (FDC) In Untreated, Unresectable or Metastatic Melanoma Participants In India

NCT07459543

Conditions: Melanoma, Metastatic Melanoma, Neoplasms, +12 more
Locations: Local Institution - 0009 Navi Mumbai, Maharashtra, India

Local Institution - 0008 Pune, Maharashtra, India

Local Institution - 0003 Bhubaneswar, Odisha, India

Local Institution - 0002 Chennai, India

View Trial Details

Not Yet Recruiting

PD-L1 Targeting Peptide Probe for PET Imaging of Solid Tumor

NCT07442292

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +23 more
Locations: Not specified

View Trial Details